Cell cycle proteins and the development of oral squamous cell carcinoma
Introduction
Progression through the cell cycle is regulated by a variety of proteins that play an important role in allowing the correct order and timing of events involved in chromosomal repair, duplication, and separation. Cyclin dependent kinases (CDK) and their regulatory partners, cyclins, form heterodimeric protein complexes that appear and degrade during predetermined steps in the cell cycle1, 2, 3. These protein complexes allow for orderly progression of the cell cycle, and also act to phosphorylate fundamental cell cycle proteins, such as retinoblastoma protein (pRb)4, 5, 6, 7.
Phosphorylation of pRb during the G1 phase of the cell cycle allows for transition from G1 to S-phase through release of transcription factors important in the induction of S-phase8, 9, 10, 11, 12. Many cyclins and CDK's have been identified, as well as three members of the pRb family13, 14, 15, 16, 17. These proteins have been mapped according to their appearance in specific periods of the cell cycle, as well as to their protein binding partners[18]. Rb mutations and altered patterns of pRb expression have been demonstrated in a wide variety of human tumors, including oral cavity and head and neck squamous cell carcinoma19, 20, 21, 22. Cyclin D1 is an unstable protein essential for G1 progression, through complex formation with CDK4, and pRb binding[8]. Cyclin D1 gene amplification and protein over expression have been found in both breast cancer and head and neck squamous cell cancers23, 24, 25, 26, 27, 28.
In addition to regulation by cyclin binding and phosphorylation, cyclin dependent kinases are regulated by specific proteins called cyclin dependent kinase inhibitors (CDKI)29, 30. CDKI's in mammals fall into two general families; the p21 family (p21Cip1/WAF1, p27Kip1 , and p57Kip2), and the INK4 family (p15INK4b, p16INK4a, p18INK4c, and p19INK4d)31, 32, 33, 34, 35, 36, 37, 38, 39, 40. The CDK inhibitor p16 binds to CDK4 and CDK6, inhibits phosphorylation of Rb, leading to G1 arrest8, 41. Loss of p16 function has been demonstrated in a wide variety of human tumors, including oral and esophageal cancer42, 43, 44, 45, 46, 47. p21 acts on multiple cyclin/CDK complexes to effect arrest of the G1/S-phase of the cell cycle31, 48, 49, 50, 51, 52. This protein is frequently expressed in epithelial cells, and may play a role in maintaining cells in a non-mitotic condition53, 54. p21 has been shown to be transcriptionally regulated by the tumor suppressor protein p53, providing an important possible explanation for p53 mediated cell cycle G1 arrest31, 50, 55, 56. p21 induction can also be accomplished by a p53 independent pathway57, 58, 59.
The role of wild type p53 protein in inducing cell cycle arrest to allow for repair of damaged DNA has been well characterized60, 61, 62. Under certain conditions, (e.g., DNA damage, withdrawal of growth factors) p53 activation can lead to apoptosis. Studies in cultured cells63, 64have shown that p53 protein can trigger arrest in either the G1 or G2 phase of the cell cycle. Loss of p53 function here could allow the accumulation of mutations that represent the rate limiting steps in tumor progression. Loss of p53 function has been demonstrated in about one half of all human cancers, including oral squamous cell carcinoma[60].
The CKI p27Kip1 shares sequence homology with p21, and acts as a p53 independent negative cell cycle regulator involved in G1 arrest32, 33, 65. This protein also associates with several cyclin-CDK complexes, resulting in loss of their activity, and failure to phosphorylate Rb. The p27 gene has not been associated with mutations in human tumors, although underexpression has been demonstrated in oral cancers66, 67.
The purpose of this investigation was to evaluate the expression of cell cycle regulatory proteins (Cyclin D1, Rb, p21, p27, p53) in sequential pre-malignant (focal keratosis, dysplasia,) and malignant (carcinoma in situ, squamous cell carcinoma) lesions arising in the oral cavity to test the hypothesis that protein regulation of the cell cycle is altered in the development of oral squamous cell carcinoma. The proliferative index was also assessed by the evaluation of expression of nuclear protein Ki67. Cases selected were archived paraffin-embedded specimens from patients with two or more sequential oral biopsies with diagnoses of focal keratosis, dysplasia of all grades, carcinoma in situ, or squamous cell carcinoma. Comparisons were made between immunohistochemical staining patterns and disease progression.
Section snippets
Study subjects
Patients with sequential biopsies of two or more oral lesions from the same or contiguous sites with the diagnoses of focal keratosis, dysplasia of all grades, carcinoma in situ, and squamous cell carcinomas of the oral cavity were selected. Individual accessions were reviewed for historical data, confirmation of histologic diagnosis, and adequacy of remaining paraffin embedded tissue. Subjects with a previous history of squamous cell carcinoma of the oral cavity, or a prior history of
Histopathology
The results of 90 formalin fixed specimens from 25 patients are displayed in Table 1Table 2. The initial histologic diagnosis for 17 of these 25 patients was either focal keratosis, mild dysplasia, or moderate dysplasia. The initial histologic diagnosis for the remaining eight patients ranged from severe dysplasia to moderately differentiated squamous cell carcinoma. The mean number of sequential biopsy specimens evaluated per subject was 3.6, with a minimum number of 2 (n=6), and a maximum of
Discussion
The increase of nuclear pRb levels in the development of malignancy initially appears inconsistent with previous reports focusing on loss of Rb function in head and neck malignancies68, 69, 70, 71, 72. However, most of the tumor specimens in these studies actually showed no loss of pRb expression, and mutations of pRb were seen in a minority of tumor specimens. In colorectal cancer, increased Rb protein expression has been demonstrated in a majority of cases, with loss of Rb function rarely seen
Acknowledgements
Supported in part by NIDR/NCI Grant P50 DE 11912.
References (96)
- Murray AW, Hunt T. The Cell Cycle: An Introduction. New York: Freeman,...
- Nurse P. Universal control mechanism in regulating onset of M-phase. Nature...
- Reed SI. The role of p34 kinases in the G1 to S-phase transition. Annual Review of Cell Biology...
- Draetta G, Beach D. Activation of cdk2 protein kinase during mitosis in human cells: cell cycle dependent...
- Morla AO, Draetta G, Beach D et al. Reversible tyrosine phosphorylation of cdc2: dephosphorylation accompanies...
- Buchkovich K, Duffy LA, Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell...
- Decaprio JA, Ludlow JW, Lynch D et al. Retinoblastoma susceptibility gene has properties of a cell cycle regulatory...
- Cordon-Cardo C. Mutation of cell cycle regulators: biological and clinical implications for human neoplasia. Am. J....
- Goodger NM, Gannon J, Hunt T, Morgan PR. Cell cycle regulatory proteins: an overview with relevance to oral cancer....
- Oswald F, Lovec H, Moroy T, Lipp M. E2F-dependent regulation of human myc: trans-activation by cyclins D1 and A...
Cited by (106)
Role of E2F transcription factor in oral cancer: Recent insight and advancements
2023, Seminars in Cancer BiologyExpression of cyclin D1 correlates with p27<sup>KIP1</sup> and regulates the degree of oral dysplasia and squamous cell carcinoma differentiation
2018, Oral Surgery, Oral Medicine, Oral Pathology and Oral RadiologyCitation Excerpt :Relatively few studies have examined cyclin D1 protein expression in oral epithelial dysplasia, and the reported prevalence rates of cyclin D1 overexpression vary from low in low-grade oral epithelial dysplasia31 to high in all grades of oral epithelial dysplasia.32 These discrepancies and variations reflect the general lack of objective quantification methods to examine protein expression because most of the studies used subjective assessment of staining intensities,32 whereas others used semiquantitative scoring.33 In the present study, computer image analysis software was used to quantify cyclin D1 and p27KIP1 nuclear/cytoplasmic staining and therefore provided an objective assessment of protein staining levels in oral epithelial dysplasia and OSCC.
Areca nut extracts exert different effects in oral cancer cells depending on serum concentration: A clue to the various oral alterations in betel quid chewers
2014, Toxicology ReportsCitation Excerpt :However, increasing evidence has suggested that nuclear p21 may not simply induce cell cycle arrest. Accumulation of p21 in the nucleus has been shown to be correlated with poor prognosis and disease progress in OSCC [38,39]. Interestingly, p21 may facilitate G1/S transition after assembling into CCND1/Cdk2/p21/PCNA complex unless cyclin E/Cdk2 is sequestered by excessive p21 proteins [40,41].
Role of Activator Protein-1 Transcription Factor in Oral Cancer
2023, Current Cancer Therapy Reviews